The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy

British Journal of Cancer

Volumn 92, Issue 8, 2005, Pages 1442-1449

  Hudson, R ^a   Carcenac, M ^b   Smith, K ^a   Madden, L ^a   Clarke, O J ^a   Pelegrin A ^b   Greenman, J ^a   Boyle, R W ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b CENTRE VAL D AURELLE   (France)

Author keywords

Bioconjugation; Monoclonal antibodies; Photodynamic therapy

Indexed keywords

5 (4 ISOTHIOCYANATOPHENYL) 10,15,20 TRIS(3,5 DIHYDROXYPHENYL)PORPHYRIN MONOCLONAL ANTIBODY 17.1A CONJUGATE; 5 (4 ISOTHIOCYANATOPHENYL) 10,15,20 TRIS(3,5 DIHYDROXYPHENYL)PORPHYRIN MONOCLONAL ANTIBODY 35A7 CONJUGATE; 5 (4 ISOTHIOCYANATOPHENYL) 10,15,20 TRIS(3,5 DIHYDROXYPHENYL)PORPHYRIN MONOCLONAL ANTIBODY FSP 77 CONJUGATE; 5 (4 ISOTHIOCYANATOPHENYL) 10,15,20 TRIS(4 N METHYLPYRIDINIUMYL)PORPHYRIN TRICHLORIDE MONOCLONAL ANTIBODY 17.1A CONJUGATE; 5 (4 ISOTHIOCYANATOPHENYL) 10,15,20 TRIS(4 N METHYLPYRIDINIUMYL)PORPHYRIN TRICHLORIDE MONOCLONAL ANTIBODY 35A7 CONJUGATE; 5 (4 ISOTHIOCYANATOPHENYL) 10,15,20 TRIS(4 N METHYLPYRIDINIUMYL)PORPHYRIN TRICHLORIDE MONOCLONAL ANTIBODY FSP 77 CONJUGATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 17.1A; MONOCLONAL ANTIBODY 35A7; MONOCLONAL ANTIBODY FSP 77; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PORPHYRIN ISOTHIOCYANATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CROSS LINKING; DRUG BINDING; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STRUCTURE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; IMMUNOTOXINS; ISOTHIOCYANATES; MALE; MICE; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TISSUE DISTRIBUTION;

EID: 18944406296     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602517     Document Type: Article

References (28)

1. Biel MA (1998) Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 108: 1259-1267
2. Boyle RW, Dolphin D (1996) Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 64: 469-485
3. Brasseur N, Langlois R, Madeleine CL, Ouellet R, van Lier JE (1999) Receptor-mediated targeting of phthalocyanines to macrophages via covalent coupling to native or maleylated bovine serum albumin. Photochem Photobiol 69: 345-352
4. Carcenac M, Dorvillius M, Garambois V, Glaussel F, Larroque C, Langlois R, Hynes NE, van Lier JE, Pelegrin A (2001) Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates. Br J Cancer 85: 1787-1793
5. Carcenac M, Larroque C, Langlois R, van Lier JE, Artus J-C, Pelegrin A (1999) Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine. Photochem Photobiol 70: 930-936
6. Clarke OJ, Boyle RW (1999) Isothiocyanatoporphyrins, useful intermediates for the conjugation of porphyrins with biomolecules and solid supports. Chem Commun 2231-2232
7. Cuello M, Ettenberg SA, Clark AS, Keane MM, Posner RH, Nau MM, Dennis PA, Lipkowitz S (2001) Down-regulation of the erbB-2 Receptor by trastuzumab (Herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res 61: 4892-4900
8. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90: 889-905
9. 2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer 75: 837-844
10. 6 selectively potentiates its photodynamic activity. Cancer Res 60: 2197-2202
11. Goff BA, Bamberg M, Hasan T (1991) Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res 51: 4762-4767
12. 6 conjugates. Br J Cancer 82: 56-64
13. Hamblin MR, Del Governatore M, Rizvi I, Hasan T (2000) Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer 83: 1544-1551
14. Hamblin MR, Miller JL, Hasan T (1996) Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res 56: 5205-5210
15. Jiang FN, Jiang S, Liu D, Richter A, Levy JG (1990) Development of technology for linking photosensitizers to a model monoclonal antibody. J Immunol Methods 134: 139-149
16. Khare PD, Shao-Xi L, Kuroki M, Hirose Y, Arakawa F, Nakamura K, Tomita Y, Kuroki M (2001) Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase. Cancer Res 61: 370-375
17. Kubler AC, Haase T, Staff C, Kahle B, Rheinwald M, Muhling J (1999) Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg Med 25: 60-68
18. Macdonald IJ, Dougherty TJ (2001) Basic Principles of Photodynamic Therapy. J Porphyrins Phthalocyanines 5: 105-129
19. Mew D, Wat CK, Towers GHN, Levy JG (1983) Photoimmunotherapy: treatment of animal tumours with tumour-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol 130: 1473-1477
20. Nseyo UO, Shumaker B, Klein EA, Sutherland K (1998) Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. J Urol 160: 39-44
21. Pardridge WM, Buciak J, Yang J, Wu D (1998) Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein. J Pharmacol Exp Ther 286: 548-554
22. Savellano MD, Hasan T (2003) Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates. Photochem Photobiol 77: 431-439
23. Shen WC, Ryser HJ (1978) Conjugation of poly-L-lysine to albumin and horse radish peroxidase: a novel method of enhancing the cellular uptake of proteins. Acad Sci USA 75: 1872-1876
24. Sutton JM, Clarke OJ, Fernandez N, Boyle RW (2002) Porphyrin, chlorin, and bacteriochlorin isothiocyanates: useful reagents for the synthesis of photoactive bioconjugates. Bioconjugate Chem 13: 249-263
25. Swamy N, James DA, Mohr SC, Hanson RN, Ray R (2002) An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells. Bioorg Med Chem 10: 3237-3243
26. Vrouenraets MB, Visser GWM, Loup C, Meunier B, Stigter M, Oppelaar H, Stewart FA, Snow GB, van Dongen GAMS (2000) Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: a new possibility for use in photodynamic therapy. Int J Cancer 88: 108-114
27. Vrouenraets MB, Visser GWM, Stewart FA, Stigter M, Oppelaar H, Postmus PE, Snow GB, van Dongen GAMS (1999) Development of meta- tetrahydroxyphenylchlorin - monoclonal antibody conjugates for photoimmunotherapy. Cancer Res 59: 1505-1513
28. Vrouenraets MB, Visser GWM, Stigter M, Oppelaar H, Snow GB, van Dongen GAMS (2001) Targeting of aluminium (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy. Cancer Res 61: 1970-1975